These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2468058)

  • 81. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.
    Shahid M; Martorana MG; Cottney JE; Marshall RJ
    Br J Pharmacol; 1990 Aug; 100(4):735-42. PubMed ID: 2169938
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline.
    Venuti MC; Stephenson RA; Alvarez R; Bruno JJ; Strosberg AM
    J Med Chem; 1988 Nov; 31(11):2136-45. PubMed ID: 2846839
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mechanisms of desensitization to a PDE inhibitor (milrinone) in conscious dogs with heart failure.
    Sato N; Asai K; Okumura S; Takagi G; Shannon RP; Fujita-Yamaguchi Y; Ishikawa Y; Vatner SF; Vatner DE
    Am J Physiol; 1999 May; 276(5):H1699-705. PubMed ID: 10330256
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
    Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
    Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Improvement by trapidil of cardiac function of the dog heart-lung preparation depressed by pentobarbital.
    Satoh K; Kawada M; Taira N
    Jpn Heart J; 1983 May; 24(3):399-405. PubMed ID: 6876384
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Improvement of drug-induced cardiac failure by NKH477, a novel forskolin derivative, in the dog heart-lung preparation.
    Fujita A; Takahira T; Hosono M; Nakamura K
    Jpn J Pharmacol; 1992 Apr; 58(4):375-81. PubMed ID: 1405034
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Apelin ameliorated acute heart failure via inhibiting endoplasmic reticulum stress in rabbits.
    Li Y; Lu H; Xu W; Shang Y; Zhao C; Wang Y; Yang R; Jin S; Wu Y; Wang X; Teng X
    Amino Acids; 2021 Mar; 53(3):417-427. PubMed ID: 33609179
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification and characterization of isoenzymes of cyclic nucleotide phosphodiesterase in human kidney and heart, and the effects of new cardiotonic agents on these isoenzymes.
    Sugioka M; Ito M; Masuoka H; Ichikawa K; Konishi T; Tanaka T; Nakano T
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):284-93. PubMed ID: 7824045
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Amlodipine induces a flow and pressure-independent vasoactive effect on the brachial artery in hypertension.
    Megnien JL; Levenson J; Del-Pino M; Simon A
    Br J Clin Pharmacol; 1995 Jun; 39(6):641-9. PubMed ID: 7654482
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.
    von der Leyen H
    Klin Wochenschr; 1989 Jun; 67(12):605-15. PubMed ID: 2671473
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cardiovascular pharmacology of RS-1893, an orally active cardiotonic agent with arterial and venous vasodilator actions.
    Miyake S; Shiga H; Koike H; Mizuno H; Yorikane R; Oda T; Iijima Y; Kumakura S; Morisawa Y
    Jpn J Pharmacol; 1988 Jul; 47(3):273-83. PubMed ID: 2851676
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
    Dage RC; Roebel LE; Hsieh CP; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.
    Mochizuki N; Uchida S; Miyata H
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):983-95. PubMed ID: 7687727
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts.
    Maruyama M; Kamiya J; Kaiho T; Kobari T
    J Cardiovasc Pharmacol; 1988; 12(5):579-86. PubMed ID: 2468058
    [TBL] [Abstract][Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.